Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Asset Writedowns and Impairment (2021 - 2024)

Trulieve Cannabis has reported Asset Writedowns and Impairment over the past 4 years, most recently at $477000.0 for Q3 2024.

  • For Q3 2024, Asset Writedowns and Impairment rose 139.45% year-over-year to $477000.0; the TTM value through Sep 2024 reached $6.8 million, up 112.51%, while the annual FY2023 figure was $2.8 million, 23.97% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2024 was $477000.0 at Trulieve Cannabis, down from $5.8 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $54.6 million in Q3 2022 and troughed at -$1.4 million in Q1 2024.
  • A 4-year average of $6.6 million and a median of $1.3 million in 2022 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 1092880.0% in 2022 and later plummeted 755.35% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $5000.0 in 2021, then soared by 25000.0% to $1.3 million in 2022, then skyrocketed by 50.12% to $1.9 million in 2023, then plummeted by 74.68% to $477000.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for TCNNF at $477000.0 in Q3 2024, $5.8 million in Q2 2024, and -$1.4 million in Q1 2024.